Expert Insight and Future Perspectives for Follicular Lymphoma

Opinion
Video

Panelists close the discussion by offering insights and future perspectives on the treatment landscape for follicular lymphoma.

Related Videos
The approval for epcoritamab in patients with R/R follicular lymphoma was supported by encouraging efficacy findings from the phase 1/2 EPCORE NHL-1 trial.
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
This series features 2 KOLs.
This series features 2 KOLs.
4 KOLs are featured in this panel.
4 KOLs are featured in this panel.
relapsed or refractory mantle cell lymphoma, glofitamab, Obinutuzumab, phase 1/2 study, NCT03075696, Tycel J. Phillips, MD
A panel of 4 experts on multiple myeloma
Related Content